Search research articles
Contact Us
Filters
Showing results (51-60 of 152) with videos related to
Page
of 16
Sort By:
Fertility and Sterility
|
October 8, 2005
Metformin alters insulin signaling and viability of human granulosa cells
Barbara Sonntag, Martin Götte, Pia Wülfing, et al.
Therapeutische Umschau. Revue Therapeutique
|
January 31, 2009
[Long-cycle treatment in oral contraception]
Herbert Kuhl, Martin Birkhäuser, Alfred Mueck, et al.
Therapeutische Umschau. Revue Therapeutique
|
January 31, 2009
[Does hormonal contraception increase the risk for tumors?]
Wilhelm Braendle, Herbert Kuhl, Alfred Mueck, et al.
Journal of Cancer Research and Clinical Oncology
|
June 29, 2022
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
Jette Riecks, Arianna Parnigoni, Balázs Győrffy, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
October 31, 2014
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling
Marie-Kristin von Wahlde, Carolin Hülsewig, Christian Ruckert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2006
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
Pia Wülfing, Julia Borchard, Horst Buerger, et al.
The FEBS Journal
|
January 8, 2013
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Hebatallah Hassan, Burkhard Greve, Mauro S G Pavao, et al.
Anticancer Research
|
June 3, 2006
Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer
Martin Götte, Christian Kersting, Maria Ruggiero, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
February 23, 2010
Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study
Arrigo Fruscalzo, Serena Bertozzi, Ambrogio P Londero, et al.
Frontiers in Oncology
|
February 14, 2022
Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
Katharina Hilgers, Sherif Abdelaziz Ibrahim, Ludwig Kiesel, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 152) with videos related to
Sort By:
Page
of 16
Fertility and Sterility
|
October 8, 2005
Metformin alters insulin signaling and viability of human granulosa cells
Barbara Sonntag, Martin Götte, Pia Wülfing, et al.
Therapeutische Umschau. Revue Therapeutique
|
January 31, 2009
[Long-cycle treatment in oral contraception]
Herbert Kuhl, Martin Birkhäuser, Alfred Mueck, et al.
Therapeutische Umschau. Revue Therapeutique
|
January 31, 2009
[Does hormonal contraception increase the risk for tumors?]
Wilhelm Braendle, Herbert Kuhl, Alfred Mueck, et al.
Journal of Cancer Research and Clinical Oncology
|
June 29, 2022
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
Jette Riecks, Arianna Parnigoni, Balázs Győrffy, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
October 31, 2014
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling
Marie-Kristin von Wahlde, Carolin Hülsewig, Christian Ruckert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2006
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
Pia Wülfing, Julia Borchard, Horst Buerger, et al.
The FEBS Journal
|
January 8, 2013
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Hebatallah Hassan, Burkhard Greve, Mauro S G Pavao, et al.
Anticancer Research
|
June 3, 2006
Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer
Martin Götte, Christian Kersting, Maria Ruggiero, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
February 23, 2010
Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study
Arrigo Fruscalzo, Serena Bertozzi, Ambrogio P Londero, et al.
Frontiers in Oncology
|
February 14, 2022
Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
Katharina Hilgers, Sherif Abdelaziz Ibrahim, Ludwig Kiesel, et al.
Page
of 16